Analysis of the Variables Influencing Valproic Acid Concentration in the Serum and Cerebrospinal Fluid of Chinese Patients After Craniotomy

被引:5
|
作者
Li, Zhihong [1 ,2 ]
Gao, Weiqi [2 ]
Liu, Guifen [1 ]
Chen, Weihong [2 ]
机构
[1] Shanxi Med Univ, Sch Publ Hlth, Dept Hlth Stat, Taiyuan, Peoples R China
[2] Shanxi Med Univ, Affiliated Da Yi Hosp, Shanxi Da Yi Hosp, Dept Pharm, 99 Longcheng St, Taiyuan 030032, Peoples R China
关键词
valproic acid; cerebrospinal fluid; therapeutic drug monitoring; gender; CYP2C9; UGT1A6; BLOOD-BRAIN-BARRIER; ANTIEPILEPTIC DRUG-RESISTANCE; PLASMA-CONCENTRATIONS; MULTIDRUG-RESISTANCE; MONITORING DATA; ELDERLY-PEOPLE; P-GLYCOPROTEIN; STEADY-STATE; EPILEPSY; PHARMACOKINETICS;
D O I
10.1097/FTD.0000000000000424
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BACKGROUND: Valproic acid (VPA) has been widely used in Chinese patients after craniotomy. Many studies have focused on the influencing factors of VPA serum concentration, but conclusions are sometimes paradoxical. Furthermore, the concentration of VPA in the cerebrospinal fluid (CSF) has been rarely reported. In the present study, VPA CSF concentrations were measured, and the potential factors influencing serum concentration and CSF distribution of VPA were investigated. In addition, the functional relationship between serum and CSF concentration was explored. METHODS: Subjects were patients who underwent craniotomy and were administrated with VPA and had a lumbar puncture. Serum and CSF VPA concentrations were measured by use of the Abbott i1000 system. CYP2C9 (430 C>T, 1075 A>C, 1076 T>C, 1080 C>G), UGT1A6 (541 A>G, 552 A>C), UGT2B7 (211 G>T, 802 C>T), and ABCB1 (1236 C>T, 2677 G>T/A, 3435 C>T) genotypes were determined by direct sequencing. Information, such as age, gender, and height, was collected, and their effect on serum and CSF VPA concentrations was investigated by univariate analysis and multiple linear regression analysis. RESULTS: First, the concomitant use of carbapenems (beta' = -0.422) and UGT1A6 (552 AA -> AC) (beta' = -0.249) had a significant negative correlation with the weight-adjusted VPA serum concentration (C:W ratio), whereas CYP2C9 (1075 AA -> AC) (beta' = 0.186) and gender (female compared with male) (beta' = 0.322) showed a positive correlation with VPA serum C:W ratio. The coefficient of determination (R) was only 0.348. Second, the relationship between the serum concentration and the CSF square root of the concentration (R-2 = 0.705) had a better linear fit. Third, serum VPA concentration (beta' = 0.810), concomitant use of glycerol fructose (beta' = 0.160), and age (>= 65 compared with <65) (beta' = 0.118) showed a positive correlation (R-2 = 0.748) with the variability of square root of the concentration of the CSF. CONCLUSIONS: In Chinese patients, after craniotomy, female patients with 1 or more of CYP2C9 (1075 AC) and UGT1A6 (552 AA) genotypes required a lower VPA dosage compared with male patient. There was a better-fitted linear relationship between VPA serum and the square root of CSF concentrations. CSF VPA concentrations were relatively stable, with only age and the use of glycerol fructose having a small influence.
引用
收藏
页码:450 / 456
页数:7
相关论文
共 50 条
  • [1] Prediction of Serum-Free and Cerebrospinal Fluid Valproic Acid Levels in Patients With Hypoalbuminemia After Craniotomy
    Li, Zhihong
    Gao, Weiqi
    Liu, Guifen
    Chen, Weihong
    THERAPEUTIC DRUG MONITORING, 2020, 42 (04) : 610 - 616
  • [2] Factors Influencing Norvancomycin Concentration in Plasma and Cerebrospinal Fluid in Patients After Craniotomy and Dosing Guideline: A Population Approach
    Li, Xingang
    Wu, Yuanxing
    Sun, Shusen
    Wang, Qiang
    Zhao, Zhigang
    CLINICAL THERAPEUTICS, 2018, 40 (01) : 74 - 82
  • [3] Drug concentrations in the serum and cerebrospinal fluid of patients treated with norvancomycin after craniotomy
    Wu, Y.
    Kang, J.
    Wang, Q.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2017, 36 (02) : 305 - 311
  • [4] Drug concentrations in the serum and cerebrospinal fluid of patients treated with norvancomycin after craniotomy
    Y. Wu
    J. Kang
    Q. Wang
    European Journal of Clinical Microbiology & Infectious Diseases, 2017, 36 : 305 - 311
  • [5] DISTRIBUTION OF VALPROIC ACID IN SERUM, CEREBROSPINAL-FLUID AND SALIVA
    QUEDNOW, B
    JOHN, K
    WALTHER, H
    ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1985, 60 (02): : P43 - P43
  • [6] Drug concentrations in the serum and cerebrospinal fluid of patients treated with cefoperazone/sulbactam after craniotomy
    Qiang Wang
    Yuanxing Wu
    Biyao Chen
    Jianxin Zhou
    BMC Anesthesiology, 15
  • [7] Drug concentrations in the serum and cerebrospinal fluid of patients treated with cefoperazone/sulbactam after craniotomy
    Wang, Qiang
    Wu, Yuanxing
    Chen, Biyao
    Zhou, Jianxin
    BMC ANESTHESIOLOGY, 2015, 15
  • [8] ASSESSMENT OF VALPROIC ACID SERUM CEREBROSPINAL-FLUID TRANSPORT BY MICRODIALYSIS
    GOLDEN, PL
    BROUWER, KR
    POLLACK, GM
    PHARMACEUTICAL RESEARCH, 1993, 10 (12) : 1765 - 1771
  • [9] Factors influencing the concentration of valproic acid in patients with diagnosed epilepsy
    Szczygiel-Pilut, E.
    EPILEPSIA, 2022, 63 : 77 - 77
  • [10] DETERMINATION OF GUANIDYLACETIC ACID CONCENTRATION IN BLOOD SERUM AND CEREBROSPINAL FLUID
    SZILAGYI, KA
    ACTA PHYSIOLOGICA ACADEMIAE SCIENTIARUM HUNGARICAE, 1970, 38 (04): : 405 - &